Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611000379910Phase 4Completed
Phase 4, randomised, open-label trial of povidone-iodine in surgical site infection (SSI) (2 arms), sponsored by KMT. Primary endpoint: Wound infection within 6 weeks of delivery. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611000379910.